Study of metabolic syndrome in postmenopausal women

Authors

  • Alina Shri Sapkota Department of Biochemistry, Maharajgunj Medical Campus, Institute of Medicine, Kathmandu
  • Alisha Sapkota National Public Health Laboratory, Teku, Kathmandu
  • Kamananda Acharya Department of Biochemistry, Maharajgunj Medical Campus, Institute of Medicine, Kathmandu
  • Mithileshwer Raut Department of Biochemistry, Maharajgunj Medical Campus, Institute of Medicine, Kathmandu
  • Bharat Jha Department of Biochemistry, Maharajgunj Medical Campus, Institute of Medicine, Kathmandu

DOI:

https://doi.org/10.3126/acclm.v1i1.12307

Keywords:

Metabolic syndrome, postmenopausal women

Abstract

BACKGROUND: Various studies throughout the world have documented higher prevalence of Metabolic Syndrome (MS) and CV risk factors in postmenopausal women. Abdominal obesity, a key component of metabolic syndrome is quite prevalent in South Asian women. However, studies that have investigated the effect of menopause on the health status of Nepalese women is lacking.

METHODS: This cross-sectional study was conducted in TUTH, Kathmandu Nepal. Forty five each premenopausal and postmenopausal (defined by cessation of menstruation for ≥12 months) women visiting the General Health Checkup Unit were enrolled as participants. Metabolic syndrome was defined by IDF criteria. BP, height, weight and WC were measured and BMI was calculated while fasting blood samples were analyzed for serum biochemical markers: FBG, lipid profile.

RESULTS: This study found higher prevalence of MS in postmenopausal women (57.8%) in comparison to premenopausal women (20%). 13.3% were diabetic, 23.3% were hypertensive, 82.2% had abdominal obesity (WC>80 cm), 43.3% were overweight (BMI 25-29.99 Kg/m2) and 13.3 % were obese (BMI≥30 Kg/m2). WC, BMI and SBP were significantly higher in postmenopausal group. Among the biochemical markers, FBG, TC, LDL-C, TG were significantly higher whereas HDL-C was significantly lower in postmenopausal women than in premenopausal women.

CONCLUSION: MS was highly prevalent in postmenopausal women. This is an indication of taking necessary preventive measures so that the risk of developing diabetes and cardiovascular disease can be minimized in the postmenopausal group.

DOI: http://dx.doi.org/10.3126/acclm.v1i1.12307

Ann. Clin. Chem. & Lab. Med. 1(1) 2015: 6-11

Downloads

Download data is not yet available.
Abstract
1344
PDF
2041

Downloads

Published

2015-03-19

How to Cite

Sapkota, A. S., Sapkota, A., Acharya, K., Raut, M., & Jha, B. (2015). Study of metabolic syndrome in postmenopausal women. Annals of Clinical Chemistry and Laboratory Medicine, 1(1), 6–11. https://doi.org/10.3126/acclm.v1i1.12307

Issue

Section

Original Articles